Animab

Gent, Belgium · Founded 2020 · Privately Held (backing)

Developer of monoclonal antibodies designed to bring to the market cost-effective services that ultimately benefit animals, producers, and consumers. Animab is based in Gent, Belgium and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $25.4 million.

Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$25.4M
Last round
—

Who backs Animab?

9 investors
InvestorType
Participatiemaatschappij VlaanderenOther
VIBOther
Agri Investment FundOther
Ghent University EndowmentOther
AnacuraOther
Qbic Fund—
Seventure—
V-Bio Ventures—
Vrije Universiteit Brussel—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Animab investors

9 investors are on record for Animab, including Participatiemaatschappij Vlaanderen, VIB, Agri Investment Fund and Ghent University Endowment.

Free account
More of Animab with a free account
  • ·Watch Animab: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Animab. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View